105 related articles for article (PubMed ID: 2555296)
1. Tumor necrosis factor-alpha induces a kappa B sequence-specific DNA-binding protein in human hepatoblastoma HepG2 cells.
Banerjee R; Karpen S; Siekevitz M; Lengyel G; Bauer J; Acs G
Hepatology; 1989 Dec; 10(6):1008-13. PubMed ID: 2555296
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
Lacoste J; D'Addario M; Roulston A; Wainberg MA; Hiscott J
J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.
Lowenthal JW; Ballard DW; Böhnlein E; Greene WC
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2331-5. PubMed ID: 2494663
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
Duh EJ; Maury WJ; Folks TM; Fauci AS; Rabson AB
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of interleukin-6 gene by adenoviral E1A proteins.
Janaswami PM; Kalvakolanu DV; Zhang Y; Sen GC
J Biol Chem; 1992 Dec; 267(34):24886-91. PubMed ID: 1332971
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV-1 LTR trans-activating activities in two different human hepatocellular carcinoma cell lines.
Chang KS; Hsu ML; Josephs SF
Cancer Lett; 1993 Oct; 74(1-2):75-83. PubMed ID: 8287375
[TBL] [Abstract][Full Text] [Related]
9. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines.
Russo FO; Patel PC; Ventura AM; Pereira CA
Virus Res; 1999 Oct; 64(1):87-94. PubMed ID: 10500286
[TBL] [Abstract][Full Text] [Related]
11. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.
Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M
AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
Osborn L; Kunkel S; Nabel GJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2336-40. PubMed ID: 2494664
[TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear factor kappa B in human neuroblastoma cell lines.
Körner M; Tarantino N; Pleskoff O; Lee LM; Debré P
J Neurochem; 1994 May; 62(5):1716-26. PubMed ID: 8158122
[TBL] [Abstract][Full Text] [Related]
14. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
15. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.
Griffin GE; Leung K; Folks TM; Kunkel S; Nabel GJ
Nature; 1989 May; 339(6219):70-3. PubMed ID: 2654643
[TBL] [Abstract][Full Text] [Related]
16. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
[TBL] [Abstract][Full Text] [Related]
18. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C.
Lucito R; Schneider RJ
J Virol; 1992 Feb; 66(2):983-91. PubMed ID: 1309924
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements.
Mahé Y; Mukaida N; Kuno K; Akiyama M; Ikeda N; Matsushima K; Murakami S
J Biol Chem; 1991 Jul; 266(21):13759-63. PubMed ID: 1856209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
